Skip to Content

Corcept Therapeutics Inc CORT

Morningstar Rating
$22.45 −0.54 (2.35%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CORT is trading at a 17% discount.
Price
$22.48
Fair Value
$98.17
Uncertainty
Very High
1-Star Price
$84.24
5-Star Price
$86.60
Economic Moat
Fhysgl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CORT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$22.99
Day Range
$22.3723.07
52-Week Range
$17.8634.28
Bid/Ask
$20.50 / $22.45
Market Cap
$2.32 Bil
Volume/Avg
844,484 / 1.4 Mil

Key Statistics

Price/Earnings (Normalized)
29.88
Price/Sales
6.08
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
6.26%

Company Profile

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
352

Comparables

Valuation

Metric
CORT
NBIX
AVIR
Price/Earnings (Normalized)
29.8826.40
Price/Book Value
5.405.830.58
Price/Sales
6.087.05
Price/Cash Flow
26.5136.80
Price/Earnings
CORT
NBIX
AVIR

Financial Strength

Metric
CORT
NBIX
AVIR
Quick Ratio
4.052.2531.50
Current Ratio
4.392.4531.93
Interest Coverage
73.20
Quick Ratio
CORT
NBIX
AVIR

Profitability

Metric
CORT
NBIX
AVIR
Return on Assets (Normalized)
25.13%14.51%−14.35%
Return on Equity (Normalized)
30.53%20.57%−14.90%
Return on Invested Capital (Normalized)
27.46%17.92%−18.26%
Return on Assets
CORT
NBIX
AVIR
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRDbxp$550.2 Bil
VRTX
Vertex Pharmaceuticals IncTfbpvy$111.1 Bil
REGN
Regeneron Pharmaceuticals IncRqjsxy$107.7 Bil
MRNA
Moderna IncTtqt$36.8 Bil
ARGX
argenx SE ADRJmdyy$24.2 Bil
BNTX
BioNTech SE ADRTfrn$22.3 Bil
ALNY
Alnylam Pharmaceuticals IncWchhbsn$19.9 Bil
BMRN
Biomarin Pharmaceutical IncRfyxhb$17.2 Bil
RPRX
Royalty Pharma PLC Class ABmjkzhd$13.9 Bil
INCY
Incyte CorpCsjcpx$13.6 Bil

Sponsor Center